In mice, 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (
PhIP) induces a high incidence of
malignant lymphoma and
leukemia, but exhibits little, if any, carcinogenic activity in the large intestine after long-term exposure. However, recent studies have revealed that colonic
adenocarcinomas can be efficiently and rapidly induced by combined treatment with
PhIP and
dextran sulfate sodium (DSS), a potent inducer of
colitis. In the present study, the authors investigated the effects of
inflammation on
PhIP-induced
carcinogenesis using two mouse strains, C57BL/6J and MSM/Ms, showing distinct temporal profiles of inflammatory responses to DSS. A long-term
carcinogenesis experiment conducted with a single i.g. administration of
PhIP (200 mg/kg
body weight), followed by DSS treatment in
drinking water for 4-6 days, revealed an increase in
tumor incidence in C57BL/6J mice in accordance with the DSS intake. In contrast, neoplastic lesions were rarely observed in the MSM/Ms strain. From the short-term exposure to DSS for 4 days, C57BL/6J mice demonstrated severe chronic
colitis, accompanied by hyperplastic cryptal epithelium and extensive cellular infiltration.
Splenomegaly and swelling of mesenteric lymph nodes were also evident for over 1 month as chronic symptoms of systemic immunological disturbance. However, no inflammatory lesions were detected in MSM/Ms mice. The present results provide strong evidence that prolonged chronic inflammatory responses induced by DSS are directly responsible for the observed enhancement of
PhIP-induced large bowel carcinogenicity.